| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antifungal Agents | 20 | 2013 | 286 | 1.710 |
Why?
|
| AIDS-Related Opportunistic Infections | 18 | 2010 | 137 | 1.690 |
Why?
|
| Amphotericin B | 13 | 2013 | 90 | 1.330 |
Why?
|
| Cryptococcosis | 12 | 2013 | 42 | 1.100 |
Why?
|
| Antiretroviral Therapy, Highly Active | 9 | 2009 | 266 | 1.060 |
Why?
|
| Histoplasmosis | 13 | 2009 | 45 | 0.920 |
Why?
|
| Meningitis, Cryptococcal | 5 | 2010 | 21 | 0.700 |
Why?
|
| Fluconazole | 11 | 2013 | 47 | 0.670 |
Why?
|
| Enterocolitis, Pseudomembranous | 5 | 2007 | 93 | 0.630 |
Why?
|
| Inflammation | 4 | 2015 | 1405 | 0.620 |
Why?
|
| Metronidazole | 4 | 2007 | 155 | 0.570 |
Why?
|
| Anti-Bacterial Agents | 14 | 2021 | 2397 | 0.550 |
Why?
|
| Staphylococcus aureus | 11 | 2008 | 455 | 0.550 |
Why?
|
| Cryptococcus neoformans | 6 | 2011 | 20 | 0.530 |
Why?
|
| Mycoses | 3 | 2013 | 116 | 0.530 |
Why?
|
| Acquired Immunodeficiency Syndrome | 9 | 2007 | 232 | 0.500 |
Why?
|
| Immune Reconstitution Inflammatory Syndrome | 1 | 2015 | 19 | 0.500 |
Why?
|
| Immunomodulation | 1 | 2015 | 81 | 0.480 |
Why?
|
| Lung Diseases, Fungal | 3 | 2008 | 32 | 0.470 |
Why?
|
| Methicillin Resistance | 6 | 2008 | 117 | 0.440 |
Why?
|
| Central Nervous System Fungal Infections | 1 | 2013 | 6 | 0.430 |
Why?
|
| Scedosporium | 1 | 2013 | 7 | 0.430 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 280 | 0.420 |
Why?
|
| HIV Infections | 11 | 2009 | 1856 | 0.420 |
Why?
|
| Cross Infection | 9 | 2006 | 330 | 0.420 |
Why?
|
| Fungi | 1 | 2013 | 69 | 0.410 |
Why?
|
| Cellulitis | 3 | 2011 | 64 | 0.380 |
Why?
|
| Deoxycholic Acid | 1 | 2010 | 13 | 0.360 |
Why?
|
| Colitis, Ulcerative | 1 | 2013 | 207 | 0.350 |
Why?
|
| Thiazoles | 2 | 2007 | 97 | 0.330 |
Why?
|
| Staphylococcal Infections | 6 | 2006 | 552 | 0.320 |
Why?
|
| Community-Acquired Infections | 3 | 2006 | 240 | 0.320 |
Why?
|
| Blister | 1 | 2008 | 19 | 0.310 |
Why?
|
| Pneumonia | 3 | 2011 | 325 | 0.300 |
Why?
|
| Actinomycosis | 1 | 2008 | 7 | 0.300 |
Why?
|
| Bronchoscopy | 1 | 2008 | 153 | 0.290 |
Why?
|
| Hepatitis C | 1 | 2011 | 364 | 0.280 |
Why?
|
| Humans | 100 | 2021 | 123254 | 0.280 |
Why?
|
| Pulmonary Emphysema | 1 | 2008 | 94 | 0.280 |
Why?
|
| Mediastinum | 1 | 2006 | 41 | 0.260 |
Why?
|
| Internal Medicine | 1 | 2007 | 147 | 0.250 |
Why?
|
| Drug Resistance, Bacterial | 4 | 2013 | 361 | 0.250 |
Why?
|
| Escherichia coli | 4 | 2013 | 983 | 0.250 |
Why?
|
| Fluoroquinolones | 3 | 2013 | 92 | 0.250 |
Why?
|
| Middle Aged | 36 | 2013 | 26073 | 0.240 |
Why?
|
| Histoplasma | 8 | 2008 | 28 | 0.230 |
Why?
|
| Liver Cirrhosis | 1 | 2011 | 825 | 0.230 |
Why?
|
| Venous Thrombosis | 1 | 2006 | 179 | 0.230 |
Why?
|
| HIV-1 | 3 | 2005 | 463 | 0.230 |
Why?
|
| Histiocytosis, Non-Langerhans-Cell | 1 | 2004 | 15 | 0.230 |
Why?
|
| Respiration, Artificial | 2 | 1998 | 458 | 0.220 |
Why?
|
| Drug Therapy, Combination | 6 | 2008 | 1142 | 0.220 |
Why?
|
| Fever | 2 | 2000 | 296 | 0.220 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2005 | 171 | 0.220 |
Why?
|
| Male | 55 | 2013 | 60310 | 0.210 |
Why?
|
| Streptococcus pneumoniae | 3 | 1997 | 372 | 0.200 |
Why?
|
| Vancomycin | 4 | 2005 | 218 | 0.200 |
Why?
|
| DNA Fingerprinting | 5 | 1996 | 107 | 0.190 |
Why?
|
| Itraconazole | 5 | 2009 | 24 | 0.190 |
Why?
|
| Biomedical Research | 1 | 2007 | 518 | 0.190 |
Why?
|
| Adult | 38 | 2010 | 29079 | 0.180 |
Why?
|
| Endocarditis | 4 | 2013 | 101 | 0.170 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 2000 | 23 | 0.170 |
Why?
|
| Fibronectins | 6 | 1993 | 102 | 0.170 |
Why?
|
| Pseudomonas Infections | 3 | 1996 | 116 | 0.170 |
Why?
|
| Klebsiella pneumoniae | 3 | 2013 | 71 | 0.160 |
Why?
|
| Brain Abscess | 3 | 2013 | 57 | 0.160 |
Why?
|
| Ventilators, Mechanical | 1 | 1998 | 35 | 0.150 |
Why?
|
| Polymerase Chain Reaction | 5 | 1997 | 1584 | 0.150 |
Why?
|
| Pneumonia, Bacterial | 1 | 1998 | 76 | 0.140 |
Why?
|
| Education, Medical | 1 | 2021 | 289 | 0.140 |
Why?
|
| Streptomycin | 2 | 1993 | 17 | 0.140 |
Why?
|
| Internship and Residency | 1 | 2007 | 1159 | 0.140 |
Why?
|
| Endocarditis, Bacterial | 2 | 1988 | 129 | 0.140 |
Why?
|
| Anti-HIV Agents | 4 | 2009 | 304 | 0.140 |
Why?
|
| Peritonitis | 1 | 1997 | 76 | 0.130 |
Why?
|
| Students, Medical | 1 | 2021 | 361 | 0.130 |
Why?
|
| Bacterial Toxins | 3 | 2006 | 175 | 0.130 |
Why?
|
| Aged | 21 | 2010 | 19173 | 0.130 |
Why?
|
| Microbial Sensitivity Tests | 11 | 2013 | 782 | 0.130 |
Why?
|
| Female | 31 | 2011 | 65598 | 0.130 |
Why?
|
| Respiratory Insufficiency | 1 | 1998 | 231 | 0.130 |
Why?
|
| Burkholderia cepacia | 1 | 1995 | 1 | 0.130 |
Why?
|
| Streptococcal Infections | 4 | 1997 | 244 | 0.120 |
Why?
|
| Ciprofloxacin | 3 | 2013 | 66 | 0.120 |
Why?
|
| Legionella | 1 | 1994 | 9 | 0.120 |
Why?
|
| Nebulizers and Vaporizers | 1 | 1995 | 57 | 0.120 |
Why?
|
| HIV Seronegativity | 2 | 2007 | 26 | 0.120 |
Why?
|
| Acinetobacter | 1 | 1994 | 7 | 0.120 |
Why?
|
| Treatment Failure | 2 | 2007 | 335 | 0.120 |
Why?
|
| Opportunistic Infections | 3 | 2002 | 78 | 0.120 |
Why?
|
| Candidiasis | 3 | 2003 | 129 | 0.120 |
Why?
|
| Endothelium, Vascular | 3 | 1994 | 516 | 0.110 |
Why?
|
| Interferon-gamma | 2 | 2004 | 499 | 0.110 |
Why?
|
| Tetracycline Resistance | 1 | 1993 | 7 | 0.110 |
Why?
|
| Phenytoin | 1 | 1994 | 64 | 0.110 |
Why?
|
| Dermatomycoses | 1 | 2013 | 15 | 0.110 |
Why?
|
| Drug Repositioning | 1 | 2013 | 22 | 0.110 |
Why?
|
| CD4 Lymphocyte Count | 3 | 2005 | 230 | 0.110 |
Why?
|
| Risk Factors | 8 | 2015 | 10036 | 0.110 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2013 | 44 | 0.110 |
Why?
|
| DNA, Bacterial | 7 | 2013 | 474 | 0.110 |
Why?
|
| Voriconazole | 1 | 2013 | 35 | 0.110 |
Why?
|
| Syndrome | 3 | 2005 | 1116 | 0.110 |
Why?
|
| Histocytochemistry | 1 | 2013 | 99 | 0.100 |
Why?
|
| Psychosurgery | 1 | 2013 | 27 | 0.100 |
Why?
|
| Acinetobacter baumannii | 1 | 2013 | 36 | 0.100 |
Why?
|
| DNA Transposable Elements | 1 | 1993 | 177 | 0.100 |
Why?
|
| Septal Occluder Device | 1 | 2013 | 42 | 0.100 |
Why?
|
| Immunoglobulins, Intravenous | 2 | 1996 | 141 | 0.100 |
Why?
|
| Pseudomonas aeruginosa | 4 | 2008 | 166 | 0.100 |
Why?
|
| Pyridones | 1 | 2013 | 112 | 0.100 |
Why?
|
| Double-Blind Method | 5 | 2010 | 1601 | 0.100 |
Why?
|
| Respiratory Tract Infections | 1 | 1995 | 263 | 0.100 |
Why?
|
| Sequence Deletion | 2 | 1993 | 527 | 0.100 |
Why?
|
| Microscopy | 1 | 2013 | 117 | 0.100 |
Why?
|
| Rifampin | 3 | 2004 | 126 | 0.100 |
Why?
|
| Triazoles | 1 | 2013 | 138 | 0.100 |
Why?
|
| Bioprosthesis | 1 | 2013 | 111 | 0.100 |
Why?
|
| Diltiazem | 1 | 1991 | 13 | 0.100 |
Why?
|
| Suppuration | 1 | 2011 | 3 | 0.100 |
Why?
|
| Antibodies, Fungal | 1 | 2011 | 13 | 0.100 |
Why?
|
| Vulva | 1 | 2011 | 16 | 0.090 |
Why?
|
| Disease Outbreaks | 2 | 1995 | 321 | 0.090 |
Why?
|
| Tuberculosis, Hepatic | 1 | 1991 | 3 | 0.090 |
Why?
|
| Immunocompromised Host | 1 | 2013 | 295 | 0.090 |
Why?
|
| Mitral Valve | 1 | 2013 | 245 | 0.090 |
Why?
|
| Perineum | 1 | 2011 | 47 | 0.090 |
Why?
|
| Escherichia coli Infections | 2 | 2008 | 190 | 0.090 |
Why?
|
| Sulbactam | 1 | 1990 | 5 | 0.090 |
Why?
|
| Liver Abscess | 1 | 1990 | 12 | 0.090 |
Why?
|
| Ampicillin | 1 | 1990 | 58 | 0.090 |
Why?
|
| Drug Administration Schedule | 4 | 2008 | 726 | 0.090 |
Why?
|
| Retrospective Studies | 9 | 2009 | 16056 | 0.090 |
Why?
|
| Radiography | 3 | 2011 | 822 | 0.090 |
Why?
|
| Genotype | 3 | 2013 | 2537 | 0.090 |
Why?
|
| Nitro Compounds | 2 | 2007 | 18 | 0.090 |
Why?
|
| Drug Hypersensitivity | 1 | 1991 | 96 | 0.090 |
Why?
|
| Drug Combinations | 2 | 2010 | 268 | 0.090 |
Why?
|
| Case Management | 1 | 2010 | 20 | 0.090 |
Why?
|
| Clostridium Infections | 1 | 2013 | 241 | 0.090 |
Why?
|
| Aged, 80 and over | 9 | 2013 | 6385 | 0.090 |
Why?
|
| Lipids | 1 | 2013 | 513 | 0.080 |
Why?
|
| Pyrimidines | 1 | 2013 | 373 | 0.080 |
Why?
|
| Sepsis | 3 | 2006 | 476 | 0.080 |
Why?
|
| Canada | 1 | 2010 | 293 | 0.080 |
Why?
|
| Immunoglobulin G | 1 | 1992 | 769 | 0.080 |
Why?
|
| Thrombocytopenia | 1 | 1991 | 226 | 0.080 |
Why?
|
| Norfloxacin | 1 | 2008 | 4 | 0.080 |
Why?
|
| Bacterial Proteins | 3 | 2006 | 878 | 0.080 |
Why?
|
| Prevotella melaninogenica | 1 | 2008 | 2 | 0.080 |
Why?
|
| Ofloxacin | 1 | 2008 | 32 | 0.080 |
Why?
|
| Protease Inhibitors | 1 | 2009 | 93 | 0.080 |
Why?
|
| Levofloxacin | 1 | 2008 | 45 | 0.080 |
Why?
|
| Creatinine | 1 | 2010 | 382 | 0.080 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2013 | 429 | 0.080 |
Why?
|
| Incidence | 5 | 2005 | 3052 | 0.080 |
Why?
|
| Pulmonary Medicine | 1 | 2008 | 24 | 0.080 |
Why?
|
| Secondary Prevention | 2 | 2006 | 212 | 0.070 |
Why?
|
| Urology | 1 | 1989 | 75 | 0.070 |
Why?
|
| Drug Resistance, Microbial | 5 | 2013 | 192 | 0.070 |
Why?
|
| Recurrence | 4 | 2007 | 1418 | 0.070 |
Why?
|
| Benzoxazines | 1 | 2007 | 24 | 0.070 |
Why?
|
| Cough | 1 | 2008 | 86 | 0.070 |
Why?
|
| Neutrophils | 2 | 1995 | 372 | 0.070 |
Why?
|
| Receptors, IgG | 1 | 2007 | 54 | 0.070 |
Why?
|
| Amoxicillin | 1 | 2008 | 120 | 0.070 |
Why?
|
| Chest Pain | 1 | 2008 | 124 | 0.070 |
Why?
|
| Distemper Virus, Canine | 1 | 1986 | 3 | 0.070 |
Why?
|
| Osteitis Deformans | 1 | 1986 | 7 | 0.070 |
Why?
|
| Soft Tissue Infections | 1 | 2008 | 83 | 0.070 |
Why?
|
| Fatigue | 1 | 2008 | 218 | 0.070 |
Why?
|
| Endothelium | 1 | 1986 | 72 | 0.070 |
Why?
|
| Superantigens | 1 | 2006 | 20 | 0.070 |
Why?
|
| Enterotoxins | 1 | 2006 | 82 | 0.070 |
Why?
|
| United States | 8 | 2010 | 10663 | 0.060 |
Why?
|
| Arm | 1 | 2006 | 75 | 0.060 |
Why?
|
| Kidney Diseases | 1 | 2010 | 478 | 0.060 |
Why?
|
| Kidney Failure, Chronic | 1 | 2013 | 865 | 0.060 |
Why?
|
| Transplantation Conditioning | 1 | 2008 | 323 | 0.060 |
Why?
|
| Publishing | 1 | 2007 | 108 | 0.060 |
Why?
|
| Splenic Infarction | 1 | 2005 | 4 | 0.060 |
Why?
|
| Hiccup | 1 | 2005 | 6 | 0.060 |
Why?
|
| Facial Dermatoses | 1 | 2005 | 8 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2008 | 1876 | 0.060 |
Why?
|
| Drug Interactions | 3 | 2009 | 253 | 0.060 |
Why?
|
| Bartonella | 2 | 1995 | 10 | 0.060 |
Why?
|
| Antigens, CD | 1 | 2007 | 419 | 0.060 |
Why?
|
| Klebsiella Infections | 2 | 1996 | 51 | 0.060 |
Why?
|
| Azoles | 2 | 2003 | 9 | 0.060 |
Why?
|
| Edema | 1 | 2006 | 136 | 0.060 |
Why?
|
| Drug Synergism | 2 | 2004 | 239 | 0.060 |
Why?
|
| Texas | 5 | 2008 | 3567 | 0.060 |
Why?
|
| Case-Control Studies | 4 | 2007 | 3239 | 0.060 |
Why?
|
| Mycoplasma Infections | 1 | 2004 | 8 | 0.060 |
Why?
|
| Bacterial Adhesion | 3 | 1991 | 107 | 0.060 |
Why?
|
| Urinary Tract Infections | 1 | 1989 | 294 | 0.060 |
Why?
|
| Developing Countries | 1 | 2006 | 267 | 0.060 |
Why?
|
| Persian Gulf Syndrome | 1 | 2004 | 15 | 0.060 |
Why?
|
| Streptococcus pyogenes | 2 | 1996 | 77 | 0.060 |
Why?
|
| Fibrosis | 1 | 2006 | 429 | 0.060 |
Why?
|
| Weight Loss | 1 | 2008 | 481 | 0.060 |
Why?
|
| Gentamicins | 1 | 2004 | 95 | 0.060 |
Why?
|
| Intracranial Hypertension | 2 | 2010 | 120 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 807 | 0.060 |
Why?
|
| Treatment Outcome | 8 | 2010 | 12165 | 0.060 |
Why?
|
| Arthritis, Infectious | 2 | 1996 | 59 | 0.060 |
Why?
|
| Doxycycline | 1 | 2004 | 115 | 0.060 |
Why?
|
| Antibodies, Bacterial | 4 | 1996 | 382 | 0.060 |
Why?
|
| Fungemia | 1 | 2003 | 22 | 0.050 |
Why?
|
| Ketoconazole | 3 | 1993 | 10 | 0.050 |
Why?
|
| Candida | 1 | 2003 | 75 | 0.050 |
Why?
|
| Viral Load | 1 | 2005 | 381 | 0.050 |
Why?
|
| Pain | 1 | 2006 | 470 | 0.050 |
Why?
|
| Mycobacterium Infections | 1 | 2003 | 31 | 0.050 |
Why?
|
| Mucormycosis | 1 | 1983 | 26 | 0.050 |
Why?
|
| Mycobacterium bovis | 1 | 2003 | 31 | 0.050 |
Why?
|
| Animals | 10 | 2013 | 33837 | 0.050 |
Why?
|
| Anti-Infective Agents | 1 | 2005 | 266 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2005 | 539 | 0.050 |
Why?
|
| Kinetics | 1 | 2004 | 1318 | 0.050 |
Why?
|
| Equipment Contamination | 2 | 1995 | 38 | 0.050 |
Why?
|
| BCG Vaccine | 1 | 2003 | 108 | 0.050 |
Why?
|
| Diabetes Complications | 1 | 1983 | 196 | 0.050 |
Why?
|
| Flucytosine | 2 | 2000 | 17 | 0.050 |
Why?
|
| Heart Transplantation | 1 | 2008 | 854 | 0.050 |
Why?
|
| Problem-Based Learning | 1 | 2021 | 72 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 1986 | 1139 | 0.040 |
Why?
|
| Mycobacterium avium Complex | 1 | 2000 | 17 | 0.040 |
Why?
|
| Adolescent | 6 | 2010 | 19131 | 0.040 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2000 | 61 | 0.040 |
Why?
|
| Alkaline Phosphatase | 1 | 2000 | 98 | 0.040 |
Why?
|
| Child | 7 | 2010 | 24263 | 0.040 |
Why?
|
| Acute Disease | 2 | 2004 | 1093 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2005 | 6030 | 0.040 |
Why?
|
| Bacterial Typing Techniques | 3 | 1995 | 103 | 0.040 |
Why?
|
| Models, Biological | 2 | 2000 | 1449 | 0.040 |
Why?
|
| Autoimmune Diseases | 1 | 2002 | 250 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2000 | 247 | 0.040 |
Why?
|
| Prognosis | 3 | 2005 | 4515 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2004 | 744 | 0.040 |
Why?
|
| Plasmids | 3 | 1995 | 512 | 0.040 |
Why?
|
| Hospitals, University | 1 | 1998 | 96 | 0.040 |
Why?
|
| Cells, Cultured | 4 | 1994 | 3045 | 0.040 |
Why?
|
| Hospitals, Teaching | 1 | 1998 | 105 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2001 | 2115 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 1994 | 339 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2003 | 657 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2005 | 5049 | 0.040 |
Why?
|
| Pharyngitis | 1 | 1997 | 31 | 0.040 |
Why?
|
| Arthritis, Gouty | 1 | 1996 | 4 | 0.030 |
Why?
|
| Young Adult | 1 | 2010 | 8867 | 0.030 |
Why?
|
| Immunization, Passive | 1 | 1996 | 119 | 0.030 |
Why?
|
| Curriculum | 1 | 2021 | 718 | 0.030 |
Why?
|
| Base Sequence | 3 | 1995 | 3091 | 0.030 |
Why?
|
| Hypercalcemia | 1 | 1995 | 39 | 0.030 |
Why?
|
| Alopecia | 1 | 1995 | 37 | 0.030 |
Why?
|
| Drug Contamination | 1 | 1995 | 36 | 0.030 |
Why?
|
| Carrier State | 2 | 1997 | 77 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 1995 | 3867 | 0.030 |
Why?
|
| Albuterol | 1 | 1995 | 52 | 0.030 |
Why?
|
| Child, Preschool | 6 | 2010 | 13918 | 0.030 |
Why?
|
| Administration, Oral | 4 | 2006 | 669 | 0.030 |
Why?
|
| Umbilical Veins | 1 | 1994 | 71 | 0.030 |
Why?
|
| Bacteremia | 2 | 1996 | 404 | 0.030 |
Why?
|
| Phagocytosis | 3 | 1995 | 165 | 0.030 |
Why?
|
| Vitamin D | 1 | 1995 | 159 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2003 | 4705 | 0.030 |
Why?
|
| Biosynthetic Pathways | 1 | 2013 | 25 | 0.030 |
Why?
|
| Galactose | 1 | 2013 | 54 | 0.030 |
Why?
|
| Microbial Viability | 1 | 2013 | 42 | 0.030 |
Why?
|
| Polysaccharides, Bacterial | 2 | 1996 | 67 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 1993 | 114 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2013 | 113 | 0.030 |
Why?
|
| Empyema, Subdural | 1 | 1992 | 9 | 0.030 |
Why?
|
| Veterans | 1 | 2004 | 1735 | 0.030 |
Why?
|
| Spinal Cord Diseases | 1 | 1992 | 40 | 0.030 |
Why?
|
| Serotyping | 1 | 1992 | 178 | 0.020 |
Why?
|
| Antigens, Fungal | 2 | 2007 | 34 | 0.020 |
Why?
|
| Cerebrospinal Fluid | 2 | 2004 | 93 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 2 | 1995 | 257 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 293 | 0.020 |
Why?
|
| Mupirocin | 1 | 1991 | 19 | 0.020 |
Why?
|
| Multivariate Analysis | 3 | 2001 | 1413 | 0.020 |
Why?
|
| Haemophilus influenzae | 2 | 1990 | 130 | 0.020 |
Why?
|
| Minocycline | 1 | 1991 | 36 | 0.020 |
Why?
|
| Glycoproteins | 1 | 1993 | 369 | 0.020 |
Why?
|
| Escherichia coli Proteins | 1 | 2013 | 303 | 0.020 |
Why?
|
| Iron | 1 | 2013 | 262 | 0.020 |
Why?
|
| Haemophilus Infections | 2 | 1988 | 91 | 0.020 |
Why?
|
| Nasal Mucosa | 1 | 1990 | 65 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1992 | 810 | 0.020 |
Why?
|
| Nasopharynx | 1 | 1990 | 80 | 0.020 |
Why?
|
| Gas Gangrene | 1 | 1990 | 6 | 0.020 |
Why?
|
| Dysentery, Bacillary | 1 | 1990 | 10 | 0.020 |
Why?
|
| Clostridium | 1 | 1990 | 16 | 0.020 |
Why?
|
| Shigella flexneri | 1 | 1990 | 13 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 1990 | 65 | 0.020 |
Why?
|
| Syphilis | 1 | 1990 | 95 | 0.020 |
Why?
|
| Bacteria | 1 | 1993 | 483 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 2 | 2003 | 262 | 0.020 |
Why?
|
| Glomerulonephritis | 1 | 1990 | 73 | 0.020 |
Why?
|
| Paralysis | 1 | 1989 | 35 | 0.020 |
Why?
|
| Osteomyelitis | 2 | 1994 | 204 | 0.020 |
Why?
|
| HIV Reverse Transcriptase | 1 | 2009 | 12 | 0.020 |
Why?
|
| Pneumococcal Infections | 1 | 1992 | 274 | 0.020 |
Why?
|
| Hindlimb | 1 | 1989 | 75 | 0.020 |
Why?
|
| Cattle | 2 | 1989 | 562 | 0.020 |
Why?
|
| Joint Prosthesis | 1 | 1989 | 15 | 0.020 |
Why?
|
| Urodynamics | 1 | 1989 | 39 | 0.020 |
Why?
|
| Antitubercular Agents | 1 | 1991 | 246 | 0.020 |
Why?
|
| Muscles | 1 | 1989 | 288 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 1988 | 57 | 0.020 |
Why?
|
| Cephalosporins | 1 | 1989 | 138 | 0.020 |
Why?
|
| Seizures | 1 | 1994 | 874 | 0.020 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1988 | 61 | 0.020 |
Why?
|
| Diphtheria Toxoid | 1 | 1988 | 7 | 0.020 |
Why?
|
| Haemophilus Vaccines | 1 | 1988 | 30 | 0.020 |
Why?
|
| Sentinel Surveillance | 1 | 2008 | 19 | 0.020 |
Why?
|
| Time Factors | 4 | 2009 | 6222 | 0.020 |
Why?
|
| Hospitals, County | 1 | 2008 | 23 | 0.020 |
Why?
|
| Mycophenolic Acid | 1 | 2008 | 51 | 0.020 |
Why?
|
| Bacterial Vaccines | 1 | 1988 | 100 | 0.020 |
Why?
|
| Receptors, Fibronectin | 1 | 1987 | 8 | 0.020 |
Why?
|
| Thoracic Wall | 1 | 2008 | 36 | 0.020 |
Why?
|
| Debridement | 1 | 2008 | 85 | 0.020 |
Why?
|
| Biopsy | 2 | 2008 | 1236 | 0.020 |
Why?
|
| Alkynes | 1 | 2007 | 26 | 0.020 |
Why?
|
| Tacrolimus | 1 | 2008 | 99 | 0.020 |
Why?
|
| Staphylococcus | 1 | 1987 | 69 | 0.020 |
Why?
|
| Spinal Diseases | 1 | 1987 | 46 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2007 | 92 | 0.020 |
Why?
|
| Cyclopropanes | 1 | 2007 | 67 | 0.020 |
Why?
|
| Polysaccharides | 1 | 1988 | 143 | 0.020 |
Why?
|
| Mediastinitis | 2 | 2000 | 14 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 1988 | 967 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 1987 | 109 | 0.020 |
Why?
|
| Leukocidins | 1 | 2006 | 37 | 0.020 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2006 | 92 | 0.020 |
Why?
|
| Exotoxins | 1 | 2006 | 44 | 0.020 |
Why?
|
| Infant | 4 | 2008 | 12377 | 0.020 |
Why?
|
| Patient Compliance | 2 | 2004 | 470 | 0.020 |
Why?
|
| Leukocytosis | 1 | 2006 | 42 | 0.020 |
Why?
|
| Cornea | 1 | 1991 | 645 | 0.020 |
Why?
|
| Penicillins | 3 | 1996 | 154 | 0.020 |
Why?
|
| Ultrasonography | 1 | 1990 | 942 | 0.020 |
Why?
|
| Vancomycin Resistance | 1 | 2005 | 21 | 0.020 |
Why?
|
| Haplotypes | 1 | 2007 | 517 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 1988 | 372 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2006 | 209 | 0.020 |
Why?
|
| Mycoplasma | 1 | 2004 | 4 | 0.010 |
Why?
|
| Photosensitivity Disorders | 1 | 2004 | 10 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 2586 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2006 | 395 | 0.010 |
Why?
|
| Mice | 3 | 2006 | 17546 | 0.010 |
Why?
|
| Graft Rejection | 1 | 2008 | 587 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 2004 | 126 | 0.010 |
Why?
|
| Nausea | 1 | 2004 | 97 | 0.010 |
Why?
|
| Drug Resistance, Multiple, Fungal | 1 | 2003 | 1 | 0.010 |
Why?
|
| Sex Factors | 1 | 2008 | 1265 | 0.010 |
Why?
|
| DNA Primers | 2 | 1995 | 660 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 1991 | 1003 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2008 | 645 | 0.010 |
Why?
|
| Solubility | 1 | 2003 | 132 | 0.010 |
Why?
|
| Phenotype | 1 | 2013 | 4227 | 0.010 |
Why?
|
| Pregnancy | 2 | 2010 | 7128 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2007 | 1390 | 0.010 |
Why?
|
| Virulence | 2 | 1996 | 261 | 0.010 |
Why?
|
| Probiotics | 1 | 2005 | 207 | 0.010 |
Why?
|
| Rabbits | 2 | 1995 | 709 | 0.010 |
Why?
|
| Blood Bactericidal Activity | 2 | 1995 | 17 | 0.010 |
Why?
|
| Hepatitis | 1 | 2003 | 59 | 0.010 |
Why?
|
| Joint Diseases | 2 | 1994 | 33 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2003 | 1013 | 0.010 |
Why?
|
| Administration, Topical | 2 | 1991 | 141 | 0.010 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2003 | 192 | 0.010 |
Why?
|
| Age Factors | 1 | 2008 | 2806 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 1385 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2003 | 383 | 0.010 |
Why?
|
| Health Planning Guidelines | 1 | 2000 | 32 | 0.010 |
Why?
|
| Vaccination | 1 | 2005 | 947 | 0.010 |
Why?
|
| Pericarditis | 1 | 2000 | 42 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2008 | 2058 | 0.010 |
Why?
|
| Spinal Puncture | 1 | 2000 | 53 | 0.010 |
Why?
|
| Mutation | 1 | 2013 | 5765 | 0.010 |
Why?
|
| Arthritis | 1 | 2000 | 81 | 0.010 |
Why?
|
| Central Nervous System Diseases | 1 | 2000 | 105 | 0.010 |
Why?
|
| San Francisco | 1 | 1999 | 17 | 0.010 |
Why?
|
| Georgia | 1 | 1999 | 29 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 1084 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 2015 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 2001 | 0.010 |
Why?
|
| Demography | 1 | 1999 | 239 | 0.010 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2003 | 545 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2000 | 501 | 0.010 |
Why?
|
| Pharynx | 1 | 1997 | 64 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 3079 | 0.010 |
Why?
|
| O Antigens | 1 | 1996 | 8 | 0.010 |
Why?
|
| Klebsiella | 1 | 1996 | 9 | 0.010 |
Why?
|
| Immunotoxins | 1 | 1996 | 21 | 0.010 |
Why?
|
| Aztreonam | 1 | 1996 | 4 | 0.010 |
Why?
|
| Monobactams | 1 | 1996 | 5 | 0.010 |
Why?
|
| Nafcillin | 1 | 1996 | 14 | 0.010 |
Why?
|
| Random Amplified Polymorphic DNA Technique | 1 | 1996 | 5 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2000 | 378 | 0.010 |
Why?
|
| Enzymes | 1 | 1996 | 52 | 0.010 |
Why?
|
| DNA, Fungal | 1 | 1996 | 75 | 0.010 |
Why?
|
| Respiratory Burst | 1 | 1995 | 10 | 0.010 |
Why?
|
| Bartonella Infections | 1 | 1995 | 7 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 1995 | 59 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 1997 | 858 | 0.010 |
Why?
|
| Pregnancy Complications | 1 | 2000 | 503 | 0.010 |
Why?
|
| Calcitriol | 1 | 1995 | 80 | 0.010 |
Why?
|
| Complement Activation | 1 | 1995 | 52 | 0.010 |
Why?
|
| Cats | 1 | 1995 | 116 | 0.010 |
Why?
|
| DNA Restriction Enzymes | 1 | 1995 | 120 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2008 | 8112 | 0.010 |
Why?
|
| Epidemiologic Methods | 1 | 1995 | 110 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1995 | 256 | 0.010 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 1994 | 18 | 0.010 |
Why?
|
| Pyelonephritis | 1 | 1994 | 26 | 0.010 |
Why?
|
| Staphylococcal Skin Infections | 1 | 1994 | 37 | 0.010 |
Why?
|
| Species Specificity | 1 | 1995 | 550 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1995 | 369 | 0.010 |
Why?
|
| Vitronectin | 1 | 1993 | 5 | 0.010 |
Why?
|
| Patient Selection | 1 | 1997 | 683 | 0.010 |
Why?
|
| Codon | 1 | 1993 | 96 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 1995 | 400 | 0.010 |
Why?
|
| Survival Analysis | 1 | 1997 | 1473 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1993 | 287 | 0.010 |
Why?
|
| Molecular Epidemiology | 1 | 1993 | 155 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1993 | 283 | 0.010 |
Why?
|
| Abscess | 1 | 1994 | 138 | 0.010 |
Why?
|
| Epidural Space | 1 | 1992 | 23 | 0.010 |
Why?
|
| Genes, Bacterial | 1 | 1993 | 209 | 0.010 |
Why?
|
| Rhinoscleroma | 1 | 1992 | 4 | 0.010 |
Why?
|
| Tetracyclines | 1 | 1992 | 14 | 0.010 |
Why?
|
| Cartilage, Articular | 1 | 1992 | 57 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 1993 | 232 | 0.010 |
Why?
|
| Point Mutation | 1 | 1993 | 348 | 0.010 |
Why?
|
| Otitis Externa | 1 | 1992 | 5 | 0.010 |
Why?
|
| Hospitals, Veterans | 1 | 1994 | 354 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1993 | 623 | 0.010 |
Why?
|
| Empyema, Pleural | 1 | 1992 | 23 | 0.010 |
Why?
|
| Empyema | 1 | 1992 | 23 | 0.010 |
Why?
|
| Purpura | 1 | 1992 | 24 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1996 | 1078 | 0.010 |
Why?
|
| Colony Count, Microbial | 1 | 1991 | 89 | 0.010 |
Why?
|
| Knee Joint | 1 | 1992 | 160 | 0.010 |
Why?
|
| Phylogeny | 1 | 1993 | 694 | 0.010 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 1992 | 82 | 0.010 |
Why?
|
| Syphilis Serodiagnosis | 1 | 1990 | 14 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 1992 | 202 | 0.010 |
Why?
|
| Pleural Effusion | 1 | 1992 | 101 | 0.010 |
Why?
|
| Neisseria meningitidis | 1 | 1990 | 19 | 0.010 |
Why?
|
| Neurosyphilis | 1 | 1990 | 14 | 0.010 |
Why?
|
| Pneumothorax | 1 | 1992 | 80 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 1993 | 305 | 0.010 |
Why?
|
| Leukocytes | 1 | 1992 | 206 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 1992 | 268 | 0.010 |
Why?
|
| Epithelium | 1 | 1991 | 360 | 0.010 |
Why?
|
| Cardiomyopathy, Alcoholic | 1 | 1990 | 4 | 0.010 |
Why?
|
| Saliva | 1 | 1990 | 113 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1990 | 383 | 0.010 |
Why?
|
| Infection Control | 1 | 1991 | 160 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 1997 | 2852 | 0.010 |
Why?
|
| Knee Prosthesis | 1 | 1989 | 10 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1989 | 391 | 0.000 |
Why?
|
| Hip Prosthesis | 1 | 1989 | 10 | 0.000 |
Why?
|
| Alleles | 1 | 1993 | 1603 | 0.000 |
Why?
|
| Shoulder Joint | 1 | 1989 | 26 | 0.000 |
Why?
|
| Organ Size | 1 | 1989 | 419 | 0.000 |
Why?
|
| Opsonin Proteins | 1 | 1988 | 21 | 0.000 |
Why?
|
| Hemoglobins | 1 | 1989 | 303 | 0.000 |
Why?
|
| Coagulase | 1 | 1987 | 22 | 0.000 |
Why?
|
| Colonic Neoplasms | 1 | 1990 | 246 | 0.000 |
Why?
|
| Random Allocation | 1 | 1988 | 433 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1989 | 1687 | 0.000 |
Why?
|
| Reoperation | 1 | 1989 | 819 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1989 | 1009 | 0.000 |
Why?
|
| Adenocarcinoma | 1 | 1990 | 994 | 0.000 |
Why?
|
| Lung | 1 | 1989 | 1465 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 1990 | 1237 | 0.000 |
Why?
|
| Protein Binding | 1 | 1983 | 1741 | 0.000 |
Why?
|